Hubei Guangji Pharmaceutical Co., Ltd. (000952.SZ)
CNY 5.32
(0.19%)
CNY 5.32
(0.19%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -140.24 Million CNY | -378.64% |
| 2022 | 50.33 Million CNY | -54.29% |
| 2021 | 110.1 Million CNY | 47.5% |
| 2020 | 74.64 Million CNY | -14.14% |
| 2019 | 86.94 Million CNY | -49.37% |
| 2018 | 171.72 Million CNY | 63.22% |
| 2017 | 105.21 Million CNY | -25.82% |
| 2016 | 141.83 Million CNY | 577.96% |
| 2015 | 20.92 Million CNY | 109.56% |
| 2014 | -218.73 Million CNY | -9131.08% |
| 2013 | 2.42 Million CNY | 102.53% |
| 2012 | -95.56 Million CNY | -2072.22% |
| 2011 | 4.84 Million CNY | -65.34% |
| 2010 | 13.97 Million CNY | -67.49% |
| 2009 | 43 Million CNY | -51.73% |
| 2008 | 89.09 Million CNY | -51.53% |
| 2007 | 183.8 Million CNY | 1073.34% |
| 2006 | 15.66 Million CNY | 82.92% |
| 2005 | 8.56 Million CNY | 4.27% |
| 2004 | 8.21 Million CNY | 6.66% |
| 2003 | 7.7 Million CNY | -61.24% |
| 2002 | 19.86 Million CNY | -19.2% |
| 2001 | 24.58 Million CNY | -19.69% |
| 2000 | 30.61 Million CNY | -2.57% |
| 1999 | 31.42 Million CNY | 22.06% |
| 1998 | 25.74 Million CNY | -19.62% |
| 1997 | 32.03 Million CNY | 83.93% |
| 1996 | 17.41 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -51.93 Million CNY | 7.49% |
| 2024 Q1 | -50.5 Million CNY | 31.07% |
| 2024 Q2 | -56.13 Million CNY | -11.14% |
| 2023 Q3 | -41.17 Million CNY | -325.8% |
| 2023 Q4 | -73.27 Million CNY | -77.97% |
| 2023 Q1 | -45.39 Million CNY | -249.05% |
| 2023 FY | -140.24 Million CNY | -378.64% |
| 2023 Q2 | 18.23 Million CNY | 140.16% |
| 2022 FY | 50.33 Million CNY | -54.29% |
| 2022 Q4 | 30.45 Million CNY | 713.53% |
| 2022 Q1 | 8.35 Million CNY | -76.74% |
| 2022 Q2 | 16.33 Million CNY | 95.54% |
| 2022 Q3 | -4.96 Million CNY | -130.38% |
| 2021 FY | 110.1 Million CNY | 47.5% |
| 2021 Q1 | 13.83 Million CNY | -48.42% |
| 2021 Q2 | 45.88 Million CNY | 231.55% |
| 2021 Q3 | 14.46 Million CNY | -68.48% |
| 2021 Q4 | 35.92 Million CNY | 148.37% |
| 2020 FY | 74.64 Million CNY | -14.14% |
| 2020 Q4 | 26.82 Million CNY | -7.08% |
| 2020 Q2 | 32.19 Million CNY | 343.06% |
| 2020 Q3 | 28.87 Million CNY | -10.31% |
| 2020 Q1 | -13.24 Million CNY | 23.25% |
| 2019 Q1 | 30.41 Million CNY | -22.95% |
| 2019 Q3 | 41.4 Million CNY | 27.9% |
| 2019 Q4 | -17.25 Million CNY | -141.67% |
| 2019 FY | 86.94 Million CNY | -49.37% |
| 2019 Q2 | 32.37 Million CNY | 6.43% |
| 2018 Q1 | 86.93 Million CNY | 275.28% |
| 2018 FY | 171.72 Million CNY | 63.22% |
| 2018 Q4 | 39.48 Million CNY | 157.85% |
| 2018 Q3 | 15.31 Million CNY | -48.96% |
| 2018 Q2 | 30 Million CNY | -65.49% |
| 2017 Q4 | 23.16 Million CNY | -26.05% |
| 2017 FY | 105.21 Million CNY | -25.82% |
| 2017 Q1 | 24.42 Million CNY | 43.41% |
| 2017 Q2 | 26.29 Million CNY | 7.65% |
| 2017 Q3 | 31.32 Million CNY | 19.15% |
| 2016 Q1 | 23.06 Million CNY | -43.12% |
| 2016 Q2 | 33.82 Million CNY | 46.66% |
| 2016 Q4 | 17.03 Million CNY | -74.93% |
| 2016 FY | 141.83 Million CNY | 577.96% |
| 2016 Q3 | 67.92 Million CNY | 100.84% |
| 2015 Q4 | 40.54 Million CNY | 1546.83% |
| 2015 FY | 20.92 Million CNY | 109.56% |
| 2015 Q3 | 2.46 Million CNY | 115.89% |
| 2015 Q2 | -15.49 Million CNY | -134.82% |
| 2015 Q1 | -6.59 Million CNY | 95.81% |
| 2014 FY | -218.73 Million CNY | -9131.08% |
| 2014 Q4 | -157.51 Million CNY | -312.76% |
| 2014 Q3 | -38.16 Million CNY | -127.77% |
| 2014 Q2 | -16.75 Million CNY | -165.88% |
| 2014 Q1 | -6.3 Million CNY | -377.83% |
| 2013 FY | 2.42 Million CNY | 102.53% |
| 2013 Q4 | 2.26 Million CNY | 560.34% |
| 2013 Q3 | -492.69 Thousand CNY | -105.14% |
| 2013 Q2 | 9.58 Million CNY | 207.23% |
| 2013 Q1 | -8.94 Million CNY | 81.56% |
| 2012 FY | -95.56 Million CNY | -2072.22% |
| 2012 Q1 | -11.4 Million CNY | 3.64% |
| 2012 Q3 | -23.58 Million CNY | -95.18% |
| 2012 Q2 | -12.08 Million CNY | -5.94% |
| 2012 Q4 | -48.48 Million CNY | -105.58% |
| 2011 Q2 | 5.84 Million CNY | -27.14% |
| 2011 Q1 | 8.02 Million CNY | 1037.78% |
| 2011 FY | 4.84 Million CNY | -65.34% |
| 2011 Q4 | -11.83 Million CNY | -522.02% |
| 2011 Q3 | 2.8 Million CNY | -52.05% |
| 2010 Q3 | 1.04 Million CNY | -86.77% |
| 2010 Q4 | 705.63 Thousand CNY | -32.54% |
| 2010 FY | 13.97 Million CNY | -67.49% |
| 2010 Q1 | 4.32 Million CNY | -77.66% |
| 2010 Q2 | 7.9 Million CNY | 82.85% |
| 2009 Q2 | 5.05 Million CNY | 4.71% |
| 2009 Q4 | 19.34 Million CNY | 40.42% |
| 2009 FY | 43 Million CNY | -51.73% |
| 2009 Q3 | 13.77 Million CNY | 172.73% |
| 2009 Q1 | 4.82 Million CNY | 197.98% |
| 2008 FY | 89.09 Million CNY | -51.53% |
| 2008 Q4 | -4.92 Million CNY | -133.43% |
| 2008 Q3 | 14.73 Million CNY | -33.09% |
| 2008 Q2 | 22.01 Million CNY | -61.56% |
| 2008 Q1 | 57.27 Million CNY | -21.17% |
| 2007 Q3 | 82.9 Million CNY | 250.77% |
| 2007 Q4 | 72.65 Million CNY | -12.37% |
| 2007 Q2 | 23.63 Million CNY | 413.46% |
| 2007 Q1 | 4.6 Million CNY | -19.03% |
| 2007 FY | 183.8 Million CNY | 1073.34% |
| 2006 Q1 | 2.61 Million CNY | -12.08% |
| 2006 Q2 | 2.74 Million CNY | 4.9% |
| 2006 Q3 | 4.61 Million CNY | 68.01% |
| 2006 Q4 | 5.68 Million CNY | 23.2% |
| 2006 FY | 15.66 Million CNY | 82.92% |
| 2005 FY | 8.56 Million CNY | 4.27% |
| 2005 Q2 | 600.44 Thousand CNY | -71.54% |
| 2005 Q4 | 2.97 Million CNY | 3.56% |
| 2005 Q1 | 2.1 Million CNY | -9.21% |
| 2005 Q3 | 2.87 Million CNY | 378.92% |
| 2004 FY | 8.21 Million CNY | 6.66% |
| 2004 Q4 | 2.32 Million CNY | 64.26% |
| 2004 Q3 | 1.41 Million CNY | -44.55% |
| 2004 Q1 | 1.92 Million CNY | 173.46% |
| 2004 Q2 | 2.55 Million CNY | 32.54% |
| 2003 Q4 | -2.61 Million CNY | -201.28% |
| 2003 Q2 | 5.48 Million CNY | 143.98% |
| 2003 FY | 7.7 Million CNY | -61.24% |
| 2003 Q1 | 2.24 Million CNY | 250.34% |
| 2003 Q3 | 2.58 Million CNY | -52.84% |
| 2002 Q1 | 3.91 Million CNY | 0.0% |
| 2002 Q4 | 641.73 Thousand CNY | -90.77% |
| 2002 Q3 | 6.95 Million CNY | -16.82% |
| 2002 Q2 | 8.36 Million CNY | 113.83% |
| 2002 FY | 19.86 Million CNY | -19.2% |
| 2001 FY | 24.58 Million CNY | -19.69% |
| 2000 FY | 30.61 Million CNY | -2.57% |
| 1999 FY | 31.42 Million CNY | 22.06% |
| 1998 FY | 25.74 Million CNY | -19.62% |
| 1997 FY | 32.03 Million CNY | 83.93% |
| 1996 FY | 17.41 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 488.73 Million CNY | 128.696% |
| Zhejiang Zhenyuan Share Co., Ltd. | 81.64 Million CNY | 271.783% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | -215.14 Million CNY | 34.812% |
| Yifan Pharmaceutical Co., Ltd. | -551.07 Million CNY | 74.55% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 34.32 Million CNY | 508.645% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 2.45 Billion CNY | 105.71% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | -8.92 Million CNY | -1470.997% |
| Boai NKY Medical Holdings Ltd. | 493.02 Million CNY | 128.446% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 310.18 Million CNY | 145.214% |